The Hemodynamic Effects of Methylene Blue When Administered at the Onset of Cardiopulmonary Bypass
In this study we examined the hemodynamic effects of methylene blue (MB), an inhibitor of guanylate cyclase, administered during cardiopulmonary bypass (CPB) to patients taking angiotensin-converting enzyme inhibitors.
